0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Editorials |

Rheumatoid Arthritis: Anticytokine Therapies on the Horizon

William J. Koopman, MD; and Larry W. Moreland, MD
[+] Article and Author Information

The University of Alabama at Birmingham; Birmingham, AL 35294 Grant Support: In part by National Institutes of Health grant R1AR44384A. Dr. Koopman is a principal investigator for studies sponsored by Sankyo, Inc., and has participated in clinical trials sponsored by Centocor, The Immune Response Corporation, and Immunex. Dr. Moreland is the Director of the Arthritis Clinical Intervention Program at The University of Alabama at Birmingham; has been a principal investigator for clinical trials sponsored by several pharmaceutical companies; and has been a consultant for Alexion Pharmaceuticals, Amgen, Biomatrix, Boehringer Ingelheim, Centocor, Connectics, Glaxo-Wellcome, Immunex, Knoll-BASF, Pharmacia/Upjohn, Schering-Plough Research Institute, Searle, SmithKline Beecham, TAP Holdings, and Wyeth. Requests for Reprints: William J. Koopman, MD, Department of Medicine, The University of Alabama at Birmingham, 402 Diabetes Education and Research Building, 1808 Seventh Avenue South, Birmingham, AL 35294-0012.


Copyright ©2004 by the American College of Physicians


Ann Intern Med. 1998;128(3):231-233. doi:10.7326/0003-4819-128-3-199802010-00010
Text Size: A A A

The agents currently used to treat aggressive rheumatoid arthritis, the so-called disease-modifying antirheumatic drugs, were generally not developed for that purpose. At best, they reduce the destructive component of the disease modestly and inconsistently.

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)